Westfield Capital Management Company »

Cerevel Therapeutics Hldng I shares owned by Westfield Capital Management Company

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Westfield Capital Management Company from 13F filings

Historical chart of Westfield Capital Management Company investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Westfield Capital Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Westfield Capital Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $33M 786k 42.40
2023-09-30 $21M 975k 21.83
2023-06-30 $18M 576k 31.79

More positions owned by Westfield Capital Management Company

Microsoft Corporation (MSFT)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
TransDigm Group Incorporated (TDG)
NVIDIA Corporation (NVDA)
Visa Com Cl A (V)
Meta Platforms Cl A (META)
Builders FirstSource (BLDR)
Dex (DXCM)
UnitedHealth (UNH)
Servicenow (NOW)
Axon Enterprise (AXON)
Saia (SAIA)

View all positions for Westfield Capital Management Company

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I